Results 151 to 160 of about 158,858 (186)
Some of the next articles are maybe not open access.
Association of soluble PD-L1 (sPD-L1) with decreased survival in metastatic melanoma.
Journal of Clinical Oncology, 20174 Background: Membrane expression of PD-L1 on tumor cells is associated with poor survival in patients with advanced malignancies including metastatic melanoma (MM). In addition, tumor-associated PD-L1 has been proposed as a predictor of response to anti-PD-1 therapy, although responses are observed in some cases of PD-L1 negative MM.
Roxana Stefania Dronca +7 more
openaire +1 more source
Clinical Laboratory, 2023
To date, PD-L1 expression in tumor tissue, assessed by immunohistochemical stain, is clinically applicable as a predictive companion biomarker for PD-1/PD-L1 inhibitor which has been highlighted over the past several years. Before blood-based sPD-L1 enters clinical use, it is critical to establish the reference range.
Seung Hyun, Lee +6 more
openaire +2 more sources
To date, PD-L1 expression in tumor tissue, assessed by immunohistochemical stain, is clinically applicable as a predictive companion biomarker for PD-1/PD-L1 inhibitor which has been highlighted over the past several years. Before blood-based sPD-L1 enters clinical use, it is critical to establish the reference range.
Seung Hyun, Lee +6 more
openaire +2 more sources
Annals of the Rheumatic Diseases, 2020
Background: Rheumatoid arthritis (RA) is a female-predominant autoimmune disease that may affect women in childbearing age, making family planning an important issue for their life. There is a need for better understanding the mechanisms modulating RA in pregnancy and develop prognostic marker regarding adverse pregnancy outcome such as reduced birth ...
A.L. Stefanski +4 more
openaire +1 more source
Background: Rheumatoid arthritis (RA) is a female-predominant autoimmune disease that may affect women in childbearing age, making family planning an important issue for their life. There is a need for better understanding the mechanisms modulating RA in pregnancy and develop prognostic marker regarding adverse pregnancy outcome such as reduced birth ...
A.L. Stefanski +4 more
openaire +1 more source
sPD-L1 and sPD-L2 in plasma of patients with lung cancer and their clinical significance
CytokineLung cancer is the leading cause of cancer death worldwide. We aim here to determine the soluble programmed death ligand-1 (sPD-L1) and soluble programmed death ligand-2 (sPD-L2) levels in the plasma of patients with lung cancer and evaluate the clinical significance.Plasma samples from 95 lung cancer patients and 55 healthy donors were collected, and ...
Shiyang, Han +7 more
exaly +3 more sources
[Levels and Clinical Significances of sPD-1 and sPD-L1 in Peripheral Blood of Lymphoma Patients].
Zhongguo shi yan xue ye xue za zhi, 2023To observe the levels of soluble programmed cell death protein 1 (sPD-1) and soluble programmed cell death ligand 1 (sPD-L1) in peripheral blood of lymphoma patients, and reveal their clinical significances.The peripheral blood specimens and clinical data of 64 newly diagnosed lymphoma patients and 30 healthy volunteers were collected.
Xiao-Liu, Liu +4 more
openaire +1 more source
Bulletin of Experimental Biology and Medicine, 2019
The content of the soluble ligand of the immune checkpoint receptor (sPD-L1) was determined in the blood serum of 106 patients with renal cell carcinoma and 11 patients with benign kidney tumors by direct ELISA (Human sPD-L1 Platinum ELISA; Affimetrix, eBioscience). The control group included 19 healthy men and 18 women.
N E, Kushlinskii +8 more
openaire +2 more sources
The content of the soluble ligand of the immune checkpoint receptor (sPD-L1) was determined in the blood serum of 106 patients with renal cell carcinoma and 11 patients with benign kidney tumors by direct ELISA (Human sPD-L1 Platinum ELISA; Affimetrix, eBioscience). The control group included 19 healthy men and 18 women.
N E, Kushlinskii +8 more
openaire +2 more sources
Targeted Oncology, 2020
The prognostic value of soluble programmed cell death ligand-1 (sPD-L1) in patients with cancer has been inconsistent across previous studies.This meta-analysis aimed to investigate the prognostic significance of sPD-L1 in human tumors.A comprehensive search of PubMed, Web of Science, Embase, and Cochrane databases from inception to January 6, 2020 was
Xiaoyang Li, Yu Zheng, Fei Yue
openaire +2 more sources
The prognostic value of soluble programmed cell death ligand-1 (sPD-L1) in patients with cancer has been inconsistent across previous studies.This meta-analysis aimed to investigate the prognostic significance of sPD-L1 in human tumors.A comprehensive search of PubMed, Web of Science, Embase, and Cochrane databases from inception to January 6, 2020 was
Xiaoyang Li, Yu Zheng, Fei Yue
openaire +2 more sources
Zeitschrift für Gastroenterologie, 2015
Immunotherapy in cancer is a recent and very promising approach, namely the inhibition of the PD/programmed death-ligand 1 (PD-L1) axis. Here we aimed to investigate the prognostic value of a soluble form of PD-L1 in hepatocellular carcinoma (HCC) patients.HCC patients were prospectively recruited and soluble programmed death-ligand 1 (sPD-L1) levels ...
Fabian Finkelmeier +10 more
openaire +2 more sources
Immunotherapy in cancer is a recent and very promising approach, namely the inhibition of the PD/programmed death-ligand 1 (PD-L1) axis. Here we aimed to investigate the prognostic value of a soluble form of PD-L1 in hepatocellular carcinoma (HCC) patients.HCC patients were prospectively recruited and soluble programmed death-ligand 1 (sPD-L1) levels ...
Fabian Finkelmeier +10 more
openaire +2 more sources
Biotechnology and Genetic Engineering Reviews, 2023
This study explored the soluble forms of PD-1 and sPD-L1/2 in serum and urine of patients with head and neck cancer (HNCs) and associated the data with clinical state and 5-year survival. The sPD-1 and sPD-L1/2 levels were evaluated by ELISA in sufferers (N=110) and normal controls (N=82).
Yan, Lv +3 more
openaire +2 more sources
This study explored the soluble forms of PD-1 and sPD-L1/2 in serum and urine of patients with head and neck cancer (HNCs) and associated the data with clinical state and 5-year survival. The sPD-1 and sPD-L1/2 levels were evaluated by ELISA in sufferers (N=110) and normal controls (N=82).
Yan, Lv +3 more
openaire +2 more sources
Clinical Breast Cancer, 2019
Neoadjuvant chemotherapy (NAC) is widely administered in the primary treatment of triple-negative breast cancer (TNBC). However, serum biomarkers for evaluating or monitoring the curative efficacy of NAC have not been established. Accumulating data have shown that soluble programmed death 1 (sPD-1) and its ligand (sPD-L1) might be potential biomarkers ...
Yao, Li +9 more
openaire +2 more sources
Neoadjuvant chemotherapy (NAC) is widely administered in the primary treatment of triple-negative breast cancer (TNBC). However, serum biomarkers for evaluating or monitoring the curative efficacy of NAC have not been established. Accumulating data have shown that soluble programmed death 1 (sPD-1) and its ligand (sPD-L1) might be potential biomarkers ...
Yao, Li +9 more
openaire +2 more sources

